Allscripts (MDRX) Tops Q2 EPS by 2c

Allscripts (NASDAQ: MDRX) reported Q2 EPS of $0.16, versus the analyst estimate of $0.18. Revenue for the quarter came in at $370 million versus the consensus estimate of $369.98 million.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Sharon AI surges premarket; New Oriental gains, Medline slips
• BIG3 Basketball to go public via Graf Global merger at $290 million